GLR2037

· Gan & Lee Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GLR2037, covering 2026-03-12 to 2026-03-12. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Clinical Study of GLR2037 in Patients With Advanced Prostate Cancer [Phase 1]